NCT04978311

Brief Summary

In this study, the investigators will (1) examine immediate and long-term effects of MT priming with task-specific training versus MT-priming with impairment-oriented training, relative to a dose-matched control therapy on motor function, arm activities, quality of life, etc; (2) provide comprehensive evaluations based on the ICF model to identify the specific benefits of MT-priming regimens; and (3) explore demographic and clinical characteristics of participants that may predict treatment outcomes.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
21

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jul 2021

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 18, 2021

Completed
9 days until next milestone

First Posted

Study publicly available on registry

July 27, 2021

Completed
2 days until next milestone

Study Start

First participant enrolled

July 29, 2021

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2022

Completed
Last Updated

June 25, 2024

Status Verified

August 1, 2022

Enrollment Period

1 year

First QC Date

July 18, 2021

Last Update Submit

June 23, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Change from Baseline Fugl-Meyer Assessment (FMA) at 6 weeks, and 18 weeks

    The upper-extremity subscale of the FMA will be used to assess motor impairment. FMA contains 33 items (scale 0-66). The higher summed score means the greater recovery of motor impairment.

    Baseline, 6 weeks, and 18 weeks

  • Change from Baseline Motor Activity Log (MAL) at 6 weeks, and 18 weeks

    The MAL is a subjective outcome measure of an individual's real life functional upper limb performance. The MAL is administered by semi-structured interview to determine (a) how much (Amount of Use - AOU), and (b) how well the individual uses his upper limb (Quality of Movement - QOM) in real life.

    Baseline, 6 weeks and 18 weeks

Secondary Outcomes (5)

  • Change from Baseline Nottingham Extended Activities of Daily Living Scale (NEADL) at 6 weeks, and 18 weeks

    Baseline, 6 weeks and 18 weeks

  • Change from Baseline Stroke Impact Scale Version 3.0 (SIS 3.0) at 6 weeks, and 18 weeks

    Baseline, 6 weeks, and 18 weeks

  • Change from Baseline Wolf Motor Function Test (WMFT) score at 6 weeks

    Baseline and 6 weeks

  • Change from Baseline Grip and Pinch strength at 6 weeks

    Baseline and 6 weeks

  • Change from Baseline Chedoke Arm and Hand Activity Inventory (CAHAI) at 6 weeks

    Baseline and 6 weeks

Study Arms (3)

Mirror therapy (MT) priming with task-specific training

EXPERIMENTAL

In the regimen, participants will perform MT first followed by task-specific training. After completion of MT, participants will practice task-specific training that emphasizes on restoration of essential skills for daily activities. After that, the contents of home practice will be designed corresponding to treatment principles of the clinic-based intervention.

Behavioral: Mirror therapy (MT) priming with task-specific training

Mirror therapy priming with impairment-oriented training

ACTIVE COMPARATOR

In the regimen, participants will perform MT first followed by impairment-oriented training. After completion of MT, participants will practice impairment-oriented training that emphasizes on restoration of movement. After that, the contents of home practice will be designed corresponding to treatment principles of the clinic-based intervention.

Behavioral: Mirror therapy priming with impairment-oriented training

Control therapy

ACTIVE COMPARATOR

The control group will receive therapeutic training equivalent in duration to the two experimental groups. The control intervention will include practice of gross/fine motor activities, training of activities of daily living, practice to increase range of motions, muscle strengthening, as well as use of adaptive or compensatory technique to alleviate functional deficits. After that, the contents of home practice will be designed corresponding to treatment principles of the clinic-based intervention.

Behavioral: Control therapy

Interventions

In the regimen, participants will perform MT first followed by task-specific training. After completion of MT, participants will practice task-specific training that emphasizes on restoration of essential skills for daily activities. After that, the contents of home practice will be designed corresponding to treatment principles of the clinic-based intervention.

Mirror therapy (MT) priming with task-specific training

In the regimen, participants will perform MT first followed by impairment-oriented training. After completion of MT, participants will practice impairment-oriented training that emphasizes on restoration of movement. After that, the contents of home practice will be designed corresponding to treatment principles of the clinic-based intervention.

Mirror therapy priming with impairment-oriented training
Control therapyBEHAVIORAL

The control group will receive therapeutic training equivalent in duration to the two experimental groups. The control intervention will include practice of gross/fine motor activities, training of activities of daily living, practice to increase range of motions, muscle strengthening, as well as use of adaptive or compensatory technique to alleviate functional deficits. After that, the contents of home practice will be designed corresponding to treatment principles of the clinic-based intervention.

Control therapy

Eligibility Criteria

Age20 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • A first ever-stroke≧3 months
  • Baseline Fugl-Meyer assessment of upper extremity scale (FMA-UE) between 18 to 56 (Fugl-Meyer et al. 1975)
  • No excessive muscle spasticity of the affected arm (Modified Ashworth Scale \< 3 at any joints of the affected arm) (Bohannon \& Smith 1987)
  • Able to follow examiners' commands and study instructions (Mini-Mental State Examination score≧22) (Folstein et al. 1975)
  • No participation in any other experimental rehabilitation or drug studies during period of this project

You may not qualify if:

  • Concomitant neurologic, neuromuscular or orthopedic conditions that may interfere with participation of this project
  • Epilepsy within three months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Feng Yuan Hospital

Taichung, Taiwan

Location

National Taiwan University Hosipital

Taipei, 100, Taiwan

Location

MeSH Terms

Interventions

Mirror Movement Therapy

Intervention Hierarchy (Ancestors)

Physical Therapy ModalitiesRehabilitationTherapeutics

Study Officials

  • Keh-chung Lin, ScD

    School of Occupational Therapy, National Taiwan University, Taipei, Taiwan

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 18, 2021

First Posted

July 27, 2021

Study Start

July 29, 2021

Primary Completion

July 31, 2022

Study Completion

July 31, 2022

Last Updated

June 25, 2024

Record last verified: 2022-08

Locations